Central nervous system relapse in a patient with acute promyelocytic leukaemia: Does the risk stratification matter?


Sahin D. G., GÜNDÜZ E., Akay O. M., Gulbas Z.

BMJ Case Reports, 2013 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası:
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1136/bcr-2013-009456
  • Dergi Adı: BMJ Case Reports
  • Derginin Tarandığı İndeksler: Scopus
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Extramedullary relapse is an uncommon complication of acute promyelocytic leukaemia (APL). The most common site of extramedullary relapse is the central nervous system (CNS), and the majority of CNS relapses occur in patients with high-risk disease in which white blood cell count at presentation is greater than 10×103/μL. The best management of such patients is still controversial. We describe a 47-year-old man with APL who developed two CNS relapses which were diagnosed through the presence of t(15;17)(q22;q21) on PCR of the cerebrospinal fluid (CSF), despite presenting initially with intermediate-risk disease. We conclude that the intermediate risk group is very heterogeneous and these patients sometimes may behave like high-risk patients. Also, clinicians should take into account symptoms that can be related to CNS relapse in patients with APL and consider lumbar puncture even if radiological imaging does not reveal anything. Copyright 2013 BMJ Publishing Group. All rights reserved.